ClinConnect ClinConnect Logo
Search / Trial NCT06698588

Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms

Launched by SWANSEA UNIVERSITY · Nov 19, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Randomised Controlled Trial

ClinConnect Summary

This clinical trial is looking at whether omega-3 fatty acids, which are found in fish oil, can help improve sleep, mood, and behavior in children who have sleep problems and symptoms related to Autism Spectrum Disorder (ASD) or Attention-Deficit/Hyperactivity Disorder (ADHD). Instead of focusing on specific diagnoses, the study will look at individual symptoms to see which children might benefit the most from taking omega-3 supplements. This approach aims to include a wider range of children, including those who might not have a formal diagnosis but still experience challenges.

Children aged 6 to 12 years old, who can swallow capsules, may be eligible to participate if they show signs of autism or ADHD based on specific questionnaires. The study is currently recruiting participants, and kids with other neurodevelopmental disorders or certain mood and anxiety issues are welcome to join, as long as they don't have major psychiatric conditions that require hospitalization. If your child participates, they will be taking omega-3 supplements and may help researchers learn more about how these supplements can support kids facing these challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Autism Spectrum Quotient 10 score \>5 OR Conners 3 Handscored Short Parent Form T score \> 64 for either the inattention OR hyperactivity subscales OR Children Sleep Habits Questionnaire SF score \>30 Able to swallow capsules
  • Exclusion Criteria:
  • Any major psychiatric condition likely to require hospitalization (e.g., Psychotic Disorders; Eating Disorders), but NB: for representativeness of typical children with ADHD/ASD, diagnosed mood/anxiety/sleep or other neurodevelopmental disorders will not be exclusion criteria; Severe learning difficulties (e.g., Down syndrome) Any serious medical condition; (d) allergy to any ingredients of the intervention or related substances

About Swansea University

Swansea University is a leading research institution located in the United Kingdom, renowned for its commitment to innovative healthcare solutions and advancements in clinical research. With a focus on interdisciplinary collaboration, the university conducts a range of clinical trials aimed at improving patient outcomes and enhancing medical knowledge. Leveraging cutting-edge facilities and a team of expert researchers, Swansea University is dedicated to fostering an environment that prioritizes ethical standards, scientific rigor, and the translation of research findings into real-world applications. Through its dedicated clinical trial initiatives, the university plays a pivotal role in advancing evidence-based practices in the healthcare sector.

Locations

Swansea, , United Kingdom

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported